Neuroblastoma is a childhood malignancy originating from cells of the sympa
thetic nervous system, exhibiting a marked diversity in outcome, with spont
aneous regression at one end of the spectrum and severe disease and death a
t the other end. Features associated with frequent recurrence, a poor progn
osis, and high tumor stage are loss of heterozygosity in the distal region
of chromosome 1p and amplification of the N-myc gene. Patched 2 is a novel
homologue to the tumor suppressor gene Patched I, and has been mapped to 1p
32-34, a part of chromosome 1 frequently deleted in high stage neuroblastom
a tumors. RT-PCR analysis of 9 neuroblastoma cell lines showed expression o
f both Patched 1 and 2. We analyzed 14, mainly high stage, neuroblastoma tu
mors for mutations in the Patched 2 gene with denaturing HPLC using the Wav
e(TM) DNA fragment analysis system. In four tumor samples variations were d
etected within the coding sequence, and two of them gave rise to amino-acid
substitutions. These variations were, however, also detected in normal DNA
from the respective patients. We conclude that Patched 2 is expressed, but
not frequently mutated, in high stage neuroblastomas and is therefore not
likely to be involved in the genesis of this tumor.